Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachid Abaji

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics of asparaginase in acute lymphoblastic leukemiaRachid Abaji, Maja Krajinovic
Expert Opinion on Drug Metabolism & Toxicology|January 23, 2016
Current perspective on pediatric pharmacogenomicsRachid Abaji, Maja Krajinovic
Pharmacogenomics and Personalized Medicine|May 17, 2017
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseRachid Abaji, Maja Krajinovic
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|February 11, 2017
Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic FibrosisIsabelle Goyer, Massimiliano Iseppon, Céline Thibault, et al.
Anesthesia and Analgesia|March 22, 2014
Topical combinations to treat microvascular dysfunction of chronic postischemia painAndré Laferrière, Rachid Abaji, Cheng-Yu Mark Tsai, et al.
Pharmacogenomics|April 29, 2022
Characterization of the impact of the <i>MYBBP1A</i> gene and rs3809849 on asparaginase sensitivity and cellular functionsRachid Abaji, Vincent Roux, Ismahène Reguieg Yssaad, et al.
Oncotarget|June 3, 2017
Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patientsRachid Abaji, Vincent Gagné, Chang Jiang Xu, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Clinical Pharmacology and Therapeutics|June 22, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic LeukemiaRachid Abaji, Vincent Gagné, Émilie Espagne, et al.
Pharmacogenomics|November 6, 2019
Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patientsVincent Gagné, Anne Aubry-Morin, Maria Plesa, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Pharmacogenetics of asparaginase in acute lymphoblastic leukemiaRachid Abaji, Maja Krajinovic
Expert Opinion on Drug Metabolism & Toxicology|January 23, 2016
Current perspective on pediatric pharmacogenomicsRachid Abaji, Maja Krajinovic
Pharmacogenomics and Personalized Medicine|May 17, 2017
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseRachid Abaji, Maja Krajinovic
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|February 11, 2017
Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic FibrosisIsabelle Goyer, Massimiliano Iseppon, Céline Thibault, et al.
Anesthesia and Analgesia|March 22, 2014
Topical combinations to treat microvascular dysfunction of chronic postischemia painAndré Laferrière, Rachid Abaji, Cheng-Yu Mark Tsai, et al.
Pharmacogenomics|April 29, 2022
Characterization of the impact of the <i>MYBBP1A</i> gene and rs3809849 on asparaginase sensitivity and cellular functionsRachid Abaji, Vincent Roux, Ismahène Reguieg Yssaad, et al.
Oncotarget|June 3, 2017
Whole-exome sequencing identified genetic risk factors for asparaginase-related complications in childhood ALL patientsRachid Abaji, Vincent Gagné, Chang Jiang Xu, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Clinical Pharmacology and Therapeutics|June 22, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic LeukemiaRachid Abaji, Vincent Gagné, Émilie Espagne, et al.
Pharmacogenomics|November 6, 2019
Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patientsVincent Gagné, Anne Aubry-Morin, Maria Plesa, et al.
Pageof 2